Artificial Pancreas Device Systems Research Report, Share, and Forecast to 2025Posted by rekha on November 6th, 2019
“The Global Artificial Pancreas Device Systems Market was valued around US$ 94.6 Mn by 2018 and growing at a significant CAGR of 19.4% over next seven years 2019-2025 due to huge R&D investments by industry players” The global artificial pancreas device systems market accounted for US$ 94.6 Mn in 2018 and burgeoning over the forthcoming years. Some of the key factors fueling the market growth include huge R&D investments by industry players, increasing occurrence of diabetes, increment in applications in extensive scope of end-user, need for insulin and glucose administration in busy-lifestyle of diabetes patients and advancement in technology. However, side effects of the treatment and a lack of skilled professionals are hindering the market growth. Global artificial pancreas device systems market segmented on the basis of technology, end user, application and region. Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16995 Type 1 Diabetic Patients dominate the Global Artificial Pancreas Device Systems Market Based on application, global artificial pancreas device systems market is segmented intoType 1 Diabetic Patients and Type 2 Diabetic Patients. Type 1 Diabetic Patients held considerable market growth during estimated period. A fully automated artificial pancreas has become a ‘holy grail’ for type 1 diabetes. Such a device would be able to forecast how much insulin a person needs at any given moment without their input. This would not only take a big problem away. It could also advance glucose control, as the algorithm can be added precise than the person. North America Leads the Global Artificial Pancreas Device Systems market
PBI’s global artificial pancreas device systems market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.North America accounted for larger revenue share in global artificial pancreas device systems market with considerable CAGR. The growth in this region is due to growing awareness and advancement in research and development and rising number of diabetic cases. Also, Asia Pacific held significant market share during estimated period owing to high patient awareness levels together withrelatively higher healthcare expenditure levels and existence of highly developed healthcare infrastructure.
Strategic Approvals are the Key Strategies Adopted by Market Players
Global artificial pancreas device systems market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2015, DreaMed Diabetes Ltd. received CE mark approval for GlucoSitter software used for tracking the glucose level and insulin administration. Key player’s profiles in the report are MEDIUM TECHNOLOGIES (UK), Medtronic (U.S), Tandem Diabetes Care, Inc. (U.S), Beta Bionics (U.S), Johnson & Johnson (U.S), Insulet Corporation (U.S) and Bigfoot Biomedical, INC.(U.S). Precision Business Insights (PBI) in its report titled “Global Artificial Pancreas Device Systems Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market. Detailed Segmentation
By Technology o Threshold Suspended Device Systems o Treat to Range/Control to Range (TTR/CTR) o Treat to Target/ Control to Target (TTR/CTT) By End User o Hospitals o Diagnostic centres o Ambulatory surgical centres
By Application o Type 1 Diabetic Patients o Type 2 Diabetic Patients By Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-artificial-pancreas-device-systems-market/ Like it? Share it! More by this author |